Clinical Trial Update: Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing continued versus interrupted novel oral anticoagulant therapy around device surgery in patients at moderate to high risk of arterial t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thromboembolism
• Hematoma

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Hematoma | Phase 3 | Status: COMPLETED